NCT02300025View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics and Safety of Cobimetinib in Volunteers With and Without Liver Damage

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Healthy Volunteer

Interventions

DRUG

cobimetinib

single oral 10-mg dose of cobimetinib

Trial Locations (3)

32809

Orlando

92801

Anaheim

330014

Miami

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY